Market Research Logo

Global Positron Emission Tomography Market - Segmented by Product Type, Applications, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)

Global Positron Emission Tomography Market - Segmented by Product Type, Applications, End-user, and Geography - Growth, Trends, and Forecast (2018 - 2023)

The positron emission tomography market is expected to register a CAGR of 5% during the forecast period, 2018 to 2023. North America dominates the market, due to growing incidence of cancer and technological advancement in the region.

Increasing Demand for PET Analysis in Radiopharmaceuticals

The technological advancements, like the Time of Flight (TOF) and the rise in popularity of hybrid imaging systems play an important role in the nuclear medicine market growth. The hybrid imaging, using combined scanners, such as PET, is offering a promising future to the nuclear medicine industry. The growing significance of the PET technology application in cardiac and neurological disorders is expected to fuel the growth of the global market. The advancements in various approaches for PET are expected to strengthen the personalized medicine industry, based on which, a continued growth is expected in the global positron emission tomography market, during the forecast period.

Short Half Life of Diagnostics Radioisotopes

Majority of the diagnostic radioisotopes have a short half-life, owing to which, they cannot be stored for long period and have to be used within a short period after production. For example, Technetium-99 is produced from a precursor radioisotope called Molybdenum-99. Molybdenum-99 has a half-life of 66 hours. Owing to its short life, Molybdenum-99 has to reach the end-user within 66 hours, and this includes the entire duration, from the time of production in the nuclear reactor to reaching the site of use, where it will be converted to Technetium-99. While Technetium-99 has a half-life of only 6.6 hours and has to be used within this time. This pricing by the supplier results in higher price of radioisotopes. In addition, given the nature of radioisotopes, there is currently no possible way to address the issue of radioisotopes short half-life. Therefore, short half-life of radioisotopes coupled with the stringent regulatory policies is hindering the growth of the global positron emission tomography market.

North America to Show Tremendous Growth

North America dominates the positron emission tomography market, owing to high demand for precision diagnostics and technological advancement in PET technology in the region. Asia Pacific is expected to grow during the forecast period, owing to factors, such as high prevalence of cancer, growing awareness regarding early diagnosis, less stringent regulatory scenario, and presence of huge population base.

Key Developments in the Market

  • December 2017: Conemaugh Memorial Medical Center has invested in new PET/CT technology that benefits patients by providing a high quality image in half the time with half the radiation. PET-CT stands for Positron Emission Tomography and Computer Tomography scans

Reasons to Purchase this Report
  • Current and future positron emission tomography market outlook in the developed and emerging markets
  • Analysis of various perspectives of the market with the help of Porter’s five forces analysis
  • The segment that is expected to dominate the market
  • Regions that are expected to witness fastest growth during the forecast period
  • Identify the latest developments, market shares, and strategies employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in Excel)
Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.

1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Demand For PET Analysis In Radiopharmaceuticals
6.1.2 Technological Advancements In Pet Imaging For Oncology And Advanced Diagnostics Applications
6.1.3 Integration Of X-Ray Tomography (CT) Into PET
6.1.4 Others
6.2 Market Restraints
6.2.1 Shorter Half-Life Of Radioisotopes
6.2.2 Stringent Regulatory Guidelines
6.2.3 Others
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Product Type
7.1.1 Full Ring PET Scanners
7.1.2 Partial Ring PET Scanners
7.2 By Applications
7.2.1 Cardiology
7.2.2 Neurology
7.2.3 Oncology
7.2.4 Others
7.3 By End-users
7.3.1 Hospitals
7.3.2 Diagnostic Centers
7.3.3 Others
7.4 By Geography
7.4.1 North America United States Canada Mexico
7.4.2 Europe France Germany United Kingdom Italy Spain Rest of Europe
7.4.3 Asia-Pacific China Japan India Australia & New Zealand South Korea Rest of Asia-Pacific
7.4.4 Middle East & Africa GCC South Africa Rest of the Middle East & Africa
7.4.5 South America Brazil Argentina Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Agfa Healthcare
9.2 Gamma Medica Inc.
9.3 GE Healthcare
9.4 Neusoft Medical Systems
9.5 Oncovision
9.6 Koninklijke Philips N.V.
9.7 Positron Corporation
9.8 Siemens AG
9.9 List Not Exhaustive
10. Future of the Market

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report